-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GAwAfGfx+2AWI8e+6xV+1VCld+FJH47fxrguK0Woif8G0FuipenqDoOB8tydKbON F8SD4BQT/OIVcMcBRwgaGw== 0000950117-06-000841.txt : 20060222 0000950117-06-000841.hdr.sgml : 20060222 20060222161423 ACCESSION NUMBER: 0000950117-06-000841 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060216 ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers FILED AS OF DATE: 20060222 DATE AS OF CHANGE: 20060222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 06636389 BUSINESS ADDRESS: STREET 1: ONE MALCOLM AVE CITY: TETERBORO STATE: NJ ZIP: 07608 BUSINESS PHONE: 2013935000 MAIL ADDRESS: STREET 1: ONE MALCOLM AVE CITY: TETERBORO STATE: NJ ZIP: 07601 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 8-K 1 a41393.htm QUEST DIAGNOSTICS INCORPORATED

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of Earliest Event Reported): February 16, 2006

 

Commission file number 001-12215

 

Quest Diagnostics Incorporated

1290 Wall Street West

Lyndhurst, NJ 07071

(201) 393-5000

 

Delaware

(State of Incorporation)

 

16-1387862

(I.R.S. Employer Identification Number)

 

 

 

 

 

 

 

 



 

 

Item 5.02 Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers

 

On February 16, 2006, during a regularly scheduled and properly called meeting of the board of directors (the "Board") of Quest Diagnostics Incorporated (the "Company"), Mr. James F. Flaherty III, a director of the Company, notified the Board of his decision not to stand for reelection as a director of the Company at the Company's 2006 Annual Meeting of Stockholders. Mr. Flaherty's term as a director will expire on the date of the 2006 Annual Meeting of Stockholders which is currently scheduled for May 4, 2006. Mr. Flaherty's decision was not the result of any disagreement with the Company.

 



 

 

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

  February 22, 2006
       
       
  QUEST DIAGNOSTICS INCORPORATED
       
       
  By:   /s/ Leo C. Farrenkopf, Jr.  
      Leo C. Farrenkopf, Jr.
Assistant General Counsel and
Assistant Corporate Secretary
 

       

 


 

 

 

-----END PRIVACY-ENHANCED MESSAGE-----